Surrey, Canada

Wendy M Toyofuku

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 12 CIPO patents and 5 EPO patents. Top assignees: Canadian Blood Services, Canadian Bllood Services, Canadian Blood Cervices. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy M Toyofuku. Retrieved from https://idiyas.com/inventor/wendy-m-toyofuku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 42.9

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Wendy M Toyofuku

Introduction

Wendy M Toyofuku is a notable inventor based in Surrey, Canada. She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of seven patents to her name, her work focuses on acellular-based therapies aimed at modulating immune responses.

Latest Patents

One of her latest patents is titled "Acellular pro-inflammatory compositions, process for making same and methods of using same." This invention relates to acellular-based therapies for decreasing the level of regulatory T cells (Treg) and/or increasing the level of pro-inflammatory T cells (Th17) to favor immune stimulation. To provide these therapeutic effects, an allogeneic leukocyte population is contacted with another leukocyte population, and the acellular components produced are isolated. The leukocyte populations are contacted to allow pro-inflammatory allo-recognition. Acellular-based preparations and processes for achieving therapy are also provided.

Another significant patent is "Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system." This disclosure relates to cellular-based therapies for modulating the level of regulatory T cells (Treg) and/or the level of pro-inflammatory T cells (Th17/Th1). To provide these therapeutic effects, a combination comprising at least one acellular pro-tolerogenic preparation and at least one acellular pro-inflammatory preparation are administered sequentially.

Career Highlights

Wendy has worked with Canadian Blood Services, where she has contributed her expertise in immunology and therapeutic innovations. Her work has been instrumental in advancing the understanding and application of acellular therapies in clinical settings.

Collaborations

Throughout her career, Wendy has collaborated with notable professionals in her field, including Mark D Scott and Duncheng Wang. These collaborations have further enriched her research and development efforts.

Conclusion

Wendy M Toyofuku is a pioneering inventor whose work in acellular-based therapies has the potential to transform immune modulation. Her innovative patents and collaborations highlight her significant contributions to the field of immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…